Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease

Atherosclerosis

Volumn 183, Issue 1, 2005, Pages 157-162

  Erkkilä, Arja T ^a   Närvänen, Outi ^a   Lehto, Seppo ^a   Uusitupa, Matti I J ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Anticardiolipin antibodies; Coronary heart disease; Mortality; Oxidized LDL

Indexed keywords

ANTIBODY; CARDIOLIPIN ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; AUTOANTIGENS; CARDIOLIPINS; COHORT STUDIES; CORONARY DISEASE; FEMALE; FINLAND; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RISK; RISK FACTORS;

EID: 26244462107     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.02.026     Document Type: Article

References (37)

1. P.M. Ridker, N.J. Brown, and D.E. Vaughan Established and emerging plasma biomarkers in the prediction of first atherothrombotic events Circulation 109 2004 IV6 IV19
2. S. Ylä-Herttuala, W. Palinski, and M.E. Rosenfeld Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095
3. D. Steinberg, and A. Lewis Connor memorial lecture. Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
4. W. Palinski, M.E. Rosenfeld, and S. Ylä-Herttuala Low density lipoprotein undergoes oxidative modification in vivo Proc Natl Acad Sci USA 86 1989 1372 1376
5. T. Lehtimäki, S. Lehtinen, and T. Solakivi Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease Arterioscler Thromb Vasc Biol 19 1999 23 27
6. Y. Yasunobu, K. Hayashi, and T. Shingu Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols Atherosclerosis 155 2001 445 453
7. C. Iribarren, A.R. Folsom, and D.R. Jacobs Jr. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study Arterioscler Thromb Vasc Biol 17 1997 1171 1177
8. J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men Arterioscler Thromb Vasc Biol 21 2001 101 107
9. K. Shimada, H. Mokuno, and E. Matsunaga Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease Atherosclerosis 174 2004 343 347
10. J.T. Salonen, S. Ylä-Herttuala, and R. Yamamoto Autoantibody against oxidized LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
11. M. Puurunen, M. Mänttäri, and V. Manninen Antibody against oxidized low-density lipoprotein predicting myocardial infarction Arch Intern Med 154 1994 2605 2609
12. R. Wu, S. Nityanand, and L. Berglund Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction Arterioscler Thromb Vasc Biol 17 1997 3159 3163
13. M.I.J. Uusitupa, L. Niskanen, and J. Luoma Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus Arterioscler Thromb Vasc Biol 16 1996 1236 1242
14. E. Ahmed, J. Trifunovic, and B. Stegmayr Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study Stroke 30 1999 2541 2646
15. T. Inoue, T. Uchida, and H. Kamishirado Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease J Am Coll Cardiol 37 2001 1871 1876
16. J. George, D. Harats, and E. Bakshi Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty Immunol Letters 68 1999 263 266
17. A. Boullier, E. Walters-Laporte, and M. Hamon Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty Clin Chim Acta 299 2000 129 140
18. B. Eber, M. Schumacher, and F. Tatzber Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty Cardiology 84 1994 310 315
19. K.S. Ginsburg, M.H. Liang, and L. Newcomer Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis Ann Intern Med 117 1992 997 1002
20. A. Hamsten, M. Björkholm, and R. Norberg Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events Lancet 1 1986 113 116
21. O. Vaarala, M. Mänttäri, and V. Manninen Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men Circulation 91 1995 23 27
22. The Antiphospholipid Antibodies in Stroke Study (APASS) Group Anticardiolipin antibodies are an independent risk factor for first ischemic stroke Neurology 43 1993 2069 2073
23. L. Chiarugi, D. Prisco, and E. Antonucci Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty Atherosclerosis 154 2001 129 135
24. A. Bili, A.J. Moss, and C.W. Francis Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic factors, and recurrent coronary events investigators Circulation 102 2000 1258 1263
25. R. De Caterina, A. d'Ascanio, and A. Mazzone Prevalence of anticardiolipin antibodies in coronary artery disease Am J Cardiol 65 1990 922 923
26. K.V. Phadke, R.A. Phillips, and D.T.R. Clarke Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J 69 1993 391 394
27. J. Karvonen, M. Päivänsalo, Y.A. Kesäniemi, and S. Hörkkö Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis Circulation 108 2003 2107 2112
28. EUROASPIRE, Study Group EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results Eur Heart J 18 1997 1569 1582
29. I.M. Penttilä, E. Voutilainen, O. Laitinen, and P. Juutilainen Comparison of different analytical and precipitation methods for the direct estimation of high-density lipoprotein cholesterol Scand J Clin Lab Invest 41 1981 353 360
30. O. Närvänen, A. Erkkilä, and S. Ylä-Herttuala Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL Free Radic Biol Med 31 2001 769 777
31. A.T. Erkkilä, O. Närvänen, and S. Lehto Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease Arterioscler Thromb Vasc Biol 20 2000 204 209
32. S. Tsimikas, W. Palinski, and J.L. Witztum Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 21 2001 95 100
33. H. Viita, O. Närvänen, and S. Ylä-Herttuala Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein Life Sci 65 1999 783 793
34. S. Tsimikas, C. Bergmark, and R.W. Beyer Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes J Am Coll Cardiol 41 2003 360 370
35. O. Heinzlef, N. Abuaf, A. Cohen, and P. Amarenco Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study J Neurol 248 2001 373 379
36. V. Janardhan, P.A. Wolf, and C.S. Kase Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: The Framingham Cohort and Offspring Study Stroke 35 2004 736 741
37. 2-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu Heart Program Stroke 32 2001 1701 1706